Breast Cancer Screening Saves Lives

Did you know?

  • “Breast cancer is the second most common cancer among women in the U.S.” (CDC) “More women are diagnosed with breast cancer than any other type of cancer, besides skin cancer” (Cancer.Net).
  • “An estimated 281,550 women in the United States will be diagnosed with invasive breast cancer, and 49,290 women will be diagnosed with non-invasive breast cancer in 2021” (Cancer.Net)
  • “Breast cancer is the second most common cause of death from cancer in women in the U.S. after lung cancer” (Cancer.Net).

Image by Rawpixel.com on Adobe Stock

  • Whereas, white women are more likely to develop breast cancer than Black, Hispanic and Asian women, Black women are more likely to have more advanced-stage breast cancer and succumb to the disease. This difference in outcome could be due to inadequate access to mammography and low quality medical care in addition to other lifestyle issues (eating habits, BMI, etc.) that are more prevalent in some ethnic groups than others (Race/Ethnicity).
  • However, due to preventive screening and treatment options, more than 403,000 deaths were prevented between 1989 and 2018 resulting in a 41% decrease of death in women due to breast cancer (Cancer.Net).
  • Due to COVID-19, many healthcare centers delayed breast cancer screening (BCS) and diagnostic tests, including mammograms, ultrasounds, and MRIs, in many parts of the U.S. from March 2020 (COVID-19 Delayed BCS). Sadly, this adversely impacted the health outcomes of many patients who would have benefitted from early screening.

Cozeva can assist with breast cancer outreach campaigns to address gaps in preventive screenings

As a population health management tool, COZEVA allows plan administrators, provider organizations, and their practices to easily track their patients’ care opportunities

As a real-time metrics engine, COZEVA’s gap reports and powerful Analytics can better inform outreach efforts. With options to target patients by geographic area, by length of time from last screenings, or by available race, ethnicity or language data, these efforts can improve patient compliance and health outcomes during these times of uncertainty.


References:

Breast Cancer Statistics https://www.cancer.net/cancer-types/breast-cancer/statistics

Breast Cancer Statistics https://www.cdc.gov/cancer/breast/statistics/index.htm

What is Breast Cancer Screening? https://www.cdc.gov/cancer/breast/basic_info/screening.htm

COVID-19 Pandemic Delayed Breast Cancer Screening in Many Parts of the United States https://www.breastcancer.org/research-news/covid-19-delayed-screening-in-us

Race/Ethnicity https://www.breastcancer.org/risk/factors/race_ethnicity

Centers for Disease Control and Prevention (CDC) https://www.cdc.gov/cancer/breast/statistics/index.htm

We follow GDPR Privacy Guidelines

We use cookies to enhance your browsing experience. By clicking “Accept and Continue”, you consent to our use of cookies.